Foundation Medicine - Virtual Exhibit Hall -15th Annual Practical Course in Dermoscopy and Update on MM 2020 | Mayo Clinic School of Continuous Professional Development

Foundation Medicine - Exhibitor
www.foundationmedicine.com Contact Information: We are available during business days and hours, feel welcome to call/text/email us as follows: Suzy Bucher Cell: 602-317-5102 sbucher@foundationmedicine.com Mary Anderson Cell: 480-236-5195 manderson@foundationmedicine.com	Virtual Exhibit Hall Home Foundation Medicine has the only portfolio of testing with FDA-approved tissue AND blood-based testing available for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. There is also the option to add on immunohistochemistry (IHC) testing. We are the companion diagnostic testing for Melanoma patients with BRAF V600E or V600K, with proven response to therapy to the following: dabrafenib, vemurafenib, trametinib, cobimetinib + vemurafenib. In addition, we are the only companion diagnostic test for high tumor mutational burden with access to Keytruda. https://www.foundationmedicine.com/blog/tumor-mutational-burden-tmb-could-help-predict-response-to-immunotherapy We have over 450+ peer-reviewed publications on the current and potential utility of comprehensive genomic profiling and 400K patients tested with comprehensive genomic profiling in a clinical setting. All Foundation Medicine comprehensive genomic profiling tests are run in CAP accredited and CLIA certified labs. Additional Information: • Medicare covers all Foundation Medicine tests for qualifying patients who meet clinical criteria. • FoundationOne CDx and FoundationOne Liquid CDx are covered by TRICARE for qualifying patients. • Foundation Medicine’s testing experience has shown that: 79% of patients have $0 financial responsibility for testing 86% of patients have a financial responsibility of $100 or less for testing • We offer a financial program based on need for those patients that may still have out of pocket costs. Foundation Medicine Portfolio Example Melanoma Report Companion Test for Keytruda

Foundation Medicine - Exhibitor

www.foundationmedicine.com

Contact Information:
We are available during business days and hours, feel welcome to call/text/email us as follows:

Suzy Bucher
Cell: 602-317-5102
sbucher@foundationmedicine.com

Mary Anderson
Cell: 480-236-5195
manderson@foundationmedicine.com

Virtual Exhibit Hall Home

Foundation Medicine has the only portfolio of testing with FDA-approved tissue AND blood-based testing available for all solid tumors with FoundationOne®CDx and FoundationOne®Liquid CDx. In addition, FoundationOne®Heme is a laboratory developed test for hematologic malignancies, sarcomas, or solid tumors where fusion detection is desired. There is also the option to add on immunohistochemistry (IHC) testing.

We are the companion diagnostic testing for Melanoma patients with BRAF V600E or V600K, with proven response to therapy to the following: dabrafenib, vemurafenib, trametinib, cobimetinib + vemurafenib. In addition, we are the only companion diagnostic test for high tumor mutational burden with access to Keytruda.

https://www.foundationmedicine.com/blog/tumor-mutational-burden-tmb-could-help-predict-response-to-immunotherapy

We have over 450+ peer-reviewed publications on the current and potential utility of comprehensive genomic profiling and 400K patients tested with comprehensive genomic profiling in a clinical setting. All Foundation Medicine comprehensive genomic profiling tests are run in CAP accredited and CLIA certified labs.
Additional Information:
• Medicare covers all Foundation Medicine tests for qualifying patients who meet clinical criteria.
• FoundationOne CDx and FoundationOne Liquid CDx are covered by TRICARE for qualifying patients.
• Foundation Medicine’s testing experience has shown that:
79% of patients have $0 financial responsibility for testing
86% of patients have a financial responsibility of $100 or less for testing
• We offer a financial program based on need for those patients that may still have out of pocket costs.

Foundation Medicine Portfolio

Example Melanoma Report

Companion Test for Keytruda

Mayo Clinic School of Continuous Professional Development

You are here

Foundation Medicine - Virtual Exhibit Hall -15th Annual Practical Course in Dermoscopy and Update on MM 2020